BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2811465
Number of visits today
237
Number of downloads
2062933
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: González Castro N, Bjelic J, Malhotra G, Huang C, Alsaffar SH. Comparison of the Feasibility, Efficiency, and Safety of Genome Editing Technologies. Int J Mol Sci 2021;22:10355. [PMID: 34638696 DOI: 10.3390/ijms221910355] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Anaganti N, Chattopadhyay A, Di Filippo M, Hussain MM. New CRISPR Technology for Creating Cell Models of Lipoprotein Assembly and Secretion. Curr Atheroscler Rep 2023. [PMID: 36913170 DOI: 10.1007/s11883-023-01095-1] [Reference Citation Analysis]
2 Hou X, Guo X, Zhang Y, Zhang Q. CRISPR/Cas genome editing system and its application in potato. Front Genet 2023;14:1017388. [PMID: 36861125 DOI: 10.3389/fgene.2023.1017388] [Reference Citation Analysis]
3 Sun W, Jiang Z, Jiang W, Yang R. Universal chimeric antigen receptor T cell therapy - The future of cell therapy: A review providing clinical evidence. Cancer Treat Res Commun 2022;33:100638. [PMID: 36184307 DOI: 10.1016/j.ctarc.2022.100638] [Reference Citation Analysis]
4 Mariot V, Dumonceaux J. Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy. Front Genome Ed 2022;4. [DOI: 10.3389/fgeed.2022.937879] [Reference Citation Analysis]
5 Talluri S. Engineering and Design of Programmable Genome Editors. J Phys Chem B 2022. [PMID: 35819243 DOI: 10.1021/acs.jpcb.2c03761] [Reference Citation Analysis]
6 Rahman MU, Bilal M, Shah JA, Kaushik A, Teissedre PL, Kujawska M. CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease. Pharmaceutics 2022;14:1252. [PMID: 35745824 DOI: 10.3390/pharmaceutics14061252] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Song Y, Zheng Z, Lian J. Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Front Cardiovasc Med 2022;9:889519. [DOI: 10.3389/fcvm.2022.889519] [Reference Citation Analysis]
8 Hou Y, Zhang X, Sun X, Qin Q, Chen D, Jia M, Chen Y. Genetically modified rabbit models for cardiovascular medicine. Eur J Pharmacol 2022;:174890. [PMID: 35300995 DOI: 10.1016/j.ejphar.2022.174890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345